JAJamie K Alan

Jamie K Alan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Jamie K Alan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Brian Johnson

    Department of Pharmacology and Toxicology, Michigan State University , 1355 Bogue Street, East Lansing, MI 48824

    1 shared publication
  • Fatemeh Yousefsaber

    Department of Chemistry, Michigan State University , 578 S Shaw Lane, East Lansing, MI 48824

    1 shared publication
  • Kin Sing Stephen Lee

    Department of Chemistry, Michigan State University , 578 S Shaw Lane, East Lansing, MI 48824

    1 shared publication
  • Morteza Sarparast

    Department of Chemistry, Michigan State University , 578 S Shaw Lane, East Lansing, MI 48824

    1 shared publication

Latest Publications

  • Open Access

    A 96-well Platform for Maintaining Age-Synchronized Caenorhabditis elegans Populations Without Chemical or Genetic Intervention

    by Fatemeh Yousefsaber, Morteza Sarparast, Brian Johnson, Jamie K Alan, Kin Sing Stephen Lee

    Caenorhabditis elegans (C. elegans) is a well-established model for investigating the mechanisms of aging and age-related disorders. However, maintaining age-synchronized populations of C. elegans without genetic or pharmacological interventions presents significant challenges, given their high reproductive rate. The traditional method for maintaining an age-synchronized population for multi-day studies without interventions is labor-intensive and low-throughput. To address these limitations, a novel method was developed to sustain age-synchronized populations in a 96-well plate liquid culture format for up to 12 days without custom-made apparatuses. The feasibility of this method was substantially improved by optimizing the surface composition of the multi-well plate and disposables and refining culture parameters. To facilitate unbiased phenotype assessment throughout the lifespan, we used a Wmicrotracker ONE reader to monitor worm movement and viability. The overall fitness decline with aging using our method is comparable to that of worms maintained on solid culture. Lastly, using transgenic C. elegans carrying tauopathy, we demonstrated that our optimized platform yields a Z-factor in the range of 0.65–0.68 at Day 3 and Day 5 adult worms, which is well above commonly used quality thresholds for multi-well screening assays. Our method simplifies age-synchronized population maintenance, enhances progeny separation, and reduces per-assay consumable costs by reusing mesh filters and batch-treated labware, enabling screening of compounds and RNAi libraries. These advancements greatly enhance the versatility of C. elegans as a model organism, offering a scalable platform for genetic and compound screening and for comprehensive investigations into drug discovery and disease mechanisms.